Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Salat

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Annals of Hematology|December 1, 1995
Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantationC Salat, E Holler, M Schleuning, et al.
Bone Marrow Transplantation|August 3, 2005
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantationM Pihusch, H Wegner, P Goehring, et al.
Shock (Augusta, Ga.)|October 1, 1996
Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodiesC Salat, P Boekstegers, E Holler, et al.
Bone Marrow Transplantation|November 1, 1994
Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive diseaseC Salat, E Holler, B Reinhardt, et al.
European Journal of Medical Research|October 1, 1998
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot studyP Neumeister, E Hiller, M Gawaz, et al.
Bone Marrow Transplantation|March 1, 1997
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantationC Salat, E Holler, C Wolf, et al.
European Journal of Medical Research|November 25, 1996
Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive diseaseC Salat, E Holler, P Göhring, et al.
Anticancer Research|August 6, 2005
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot studyH J Stemmler, C Salat, H Lindhofer, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Annals of Hematology|December 1, 1995
Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantationC Salat, E Holler, M Schleuning, et al.
Bone Marrow Transplantation|August 3, 2005
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantationM Pihusch, H Wegner, P Goehring, et al.
Shock (Augusta, Ga.)|October 1, 1996
Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodiesC Salat, P Boekstegers, E Holler, et al.
Bone Marrow Transplantation|November 1, 1994
Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive diseaseC Salat, E Holler, B Reinhardt, et al.
European Journal of Medical Research|October 1, 1998
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot studyP Neumeister, E Hiller, M Gawaz, et al.
Bone Marrow Transplantation|March 1, 1997
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantationC Salat, E Holler, C Wolf, et al.
European Journal of Medical Research|November 25, 1996
Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive diseaseC Salat, E Holler, P Göhring, et al.
Anticancer Research|August 6, 2005
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot studyH J Stemmler, C Salat, H Lindhofer, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2011
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosisM Untch, G von Minckwitz, G E Konecny, et al.
Pageof 5